

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.17023560 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.17023560 |
| 3 | plasma membrane repair (GO:0001778) | 3.99705778 |
| 4 | regulation of early endosome to late endosome transport (GO:2000641) | 3.89281775 |
| 5 | protein retention in ER lumen (GO:0006621) | 3.78053537 |
| 6 | barbed-end actin filament capping (GO:0051016) | 3.71574483 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.71130378 |
| 8 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.59865870 |
| 9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59108687 |
| 10 | apoptotic cell clearance (GO:0043277) | 3.52996591 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.51581581 |
| 12 | apoptotic process involved in morphogenesis (GO:0060561) | 3.41028462 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36861664 |
| 14 | activation of Rac GTPase activity (GO:0032863) | 3.34078153 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31953717 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.31713704 |
| 17 | negative regulation of cell size (GO:0045792) | 3.30489206 |
| 18 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.27084550 |
| 19 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.26822475 |
| 20 | negative regulation of fatty acid transport (GO:2000192) | 3.23019640 |
| 21 | regulation of extracellular matrix disassembly (GO:0010715) | 3.22571783 |
| 22 | regulation of fatty acid oxidation (GO:0046320) | 3.22499496 |
| 23 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.20508680 |
| 24 | stress fiber assembly (GO:0043149) | 3.20495728 |
| 25 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20246333 |
| 26 | lysine metabolic process (GO:0006553) | 3.19561364 |
| 27 | lysine catabolic process (GO:0006554) | 3.19561364 |
| 28 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.16224792 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.15314374 |
| 30 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.14503712 |
| 31 | fatty acid transmembrane transport (GO:1902001) | 3.11675526 |
| 32 | regulation of p38MAPK cascade (GO:1900744) | 3.07417140 |
| 33 | protein localization to endosome (GO:0036010) | 3.06948236 |
| 34 | carnitine shuttle (GO:0006853) | 3.05555097 |
| 35 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.05382102 |
| 36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.04206254 |
| 37 | protein heterotrimerization (GO:0070208) | 3.03200415 |
| 38 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.01239404 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 2.96095136 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95756081 |
| 41 | endothelial cell chemotaxis (GO:0035767) | 2.93983785 |
| 42 | proline biosynthetic process (GO:0006561) | 2.90912337 |
| 43 | positive regulation of receptor recycling (GO:0001921) | 2.90369512 |
| 44 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.90001661 |
| 45 | regulation of cholesterol storage (GO:0010885) | 2.89940978 |
| 46 | mannose metabolic process (GO:0006013) | 2.88989019 |
| 47 | desmosome organization (GO:0002934) | 2.88746179 |
| 48 | growth hormone receptor signaling pathway (GO:0060396) | 2.88606448 |
| 49 | tricarboxylic acid metabolic process (GO:0072350) | 2.88458820 |
| 50 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85261071 |
| 51 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.81930658 |
| 52 | regulation of cholesterol homeostasis (GO:2000188) | 2.79941827 |
| 53 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.78916089 |
| 54 | cell-substrate junction assembly (GO:0007044) | 2.75550177 |
| 55 | pinocytosis (GO:0006907) | 2.74737546 |
| 56 | cardiac myofibril assembly (GO:0055003) | 2.70995235 |
| 57 | sarcomere organization (GO:0045214) | 2.69547487 |
| 58 | adherens junction assembly (GO:0034333) | 2.68475719 |
| 59 | glucose 6-phosphate metabolic process (GO:0051156) | 2.68202589 |
| 60 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.68057728 |
| 61 | pentose-phosphate shunt (GO:0006098) | 2.67412944 |
| 62 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.65054629 |
| 63 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64653255 |
| 64 | modulation by symbiont of host cellular process (GO:0044068) | 2.63869572 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 2.62856023 |
| 66 | maternal placenta development (GO:0001893) | 2.62249279 |
| 67 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.60994614 |
| 68 | negative regulation of heart growth (GO:0061117) | 2.60994614 |
| 69 | cell-cell junction maintenance (GO:0045217) | 2.60104415 |
| 70 | positive regulation of protein dephosphorylation (GO:0035307) | 2.59087886 |
| 71 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.57298169 |
| 72 | protein targeting to plasma membrane (GO:0072661) | 2.55777739 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.55676176 |
| 74 | embryonic process involved in female pregnancy (GO:0060136) | 2.54487631 |
| 75 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53813425 |
| 76 | embryo implantation (GO:0007566) | 2.53712646 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 2.53170148 |
| 78 | modulation by virus of host morphology or physiology (GO:0019048) | 2.51286080 |
| 79 | hemidesmosome assembly (GO:0031581) | 2.49661586 |
| 80 | glucose catabolic process (GO:0006007) | 2.49151617 |
| 81 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.48423727 |
| 82 | focal adhesion assembly (GO:0048041) | 2.46892642 |
| 83 | cell-substrate adherens junction assembly (GO:0007045) | 2.46892642 |
| 84 | activation of MAPKKK activity (GO:0000185) | 2.46042000 |
| 85 | valine metabolic process (GO:0006573) | 2.45859880 |
| 86 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.45515871 |
| 87 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.45514140 |
| 88 | embryonic eye morphogenesis (GO:0048048) | 2.45209276 |
| 89 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.44489090 |
| 90 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44353164 |
| 91 | 4-hydroxyproline metabolic process (GO:0019471) | 2.44351357 |
| 92 | carnitine transport (GO:0015879) | 2.44200056 |
| 93 | amino-acid betaine transport (GO:0015838) | 2.44200056 |
| 94 | protein maturation by protein folding (GO:0022417) | 2.43850531 |
| 95 | sulfur amino acid catabolic process (GO:0000098) | 2.43362823 |
| 96 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.42688150 |
| 97 | cell adhesion mediated by integrin (GO:0033627) | 2.42632566 |
| 98 | cellular response to growth hormone stimulus (GO:0071378) | 2.42574842 |
| 99 | basement membrane organization (GO:0071711) | 2.42486880 |
| 100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42378348 |
| 101 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.42019767 |
| 102 | actin filament bundle organization (GO:0061572) | 2.41945961 |
| 103 | actin filament bundle assembly (GO:0051017) | 2.41945961 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 2.40911811 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 2.39779182 |
| 106 | negative regulation of viral release from host cell (GO:1902187) | 2.38689742 |
| 107 | atrioventricular valve morphogenesis (GO:0003181) | 2.38529677 |
| 108 | embryonic foregut morphogenesis (GO:0048617) | 2.38099084 |
| 109 | regulation of extracellular matrix organization (GO:1903053) | 2.37984579 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.37876235 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.37774854 |
| 112 | carnitine transmembrane transport (GO:1902603) | 2.37678965 |
| 113 | peptidyl-proline hydroxylation (GO:0019511) | 2.37336709 |
| 114 | UV protection (GO:0009650) | 2.36780087 |
| 115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.36468566 |
| 116 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36126141 |
| 117 | skin morphogenesis (GO:0043589) | 2.35285174 |
| 118 | regulation of hippo signaling (GO:0035330) | 2.34876714 |
| 119 | positive regulation of glycogen metabolic process (GO:0070875) | 2.34545995 |
| 120 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.33109864 |
| 121 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.31457972 |
| 122 | negative regulation of focal adhesion assembly (GO:0051895) | 2.30447272 |
| 123 | negative regulation of cell junction assembly (GO:1901889) | 2.30447272 |
| 124 | negative regulation of adherens junction organization (GO:1903392) | 2.30447272 |
| 125 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.29105746 |
| 126 | fatty acid oxidation (GO:0019395) | 2.29034244 |
| 127 | adhesion of symbiont to host (GO:0044406) | 2.28899589 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 2.28516170 |
| 129 | endocytic recycling (GO:0032456) | 2.28227992 |
| 130 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.27850317 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.27197733 |
| 132 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26941090 |
| 133 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.25850037 |
| 134 | myofibril assembly (GO:0030239) | 2.25306187 |
| 135 | sodium ion export (GO:0071436) | 2.24553238 |
| 136 | modulation by virus of host process (GO:0019054) | 2.24363951 |
| 137 | negative regulation of lipid transport (GO:0032369) | 2.24343189 |
| 138 | lipid oxidation (GO:0034440) | 2.23772147 |
| 139 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.23663300 |
| 140 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.23402378 |
| 141 | semaphorin-plexin signaling pathway (GO:0071526) | 2.23066250 |
| 142 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.22363413 |
| 143 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.21779687 |
| 144 | cell communication involved in cardiac conduction (GO:0086065) | 2.21638105 |
| 145 | blood vessel endothelial cell migration (GO:0043534) | 2.20757979 |
| 146 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.20706345 |
| 147 | apoptotic process involved in development (GO:1902742) | 2.20557890 |
| 148 | eye morphogenesis (GO:0048592) | 2.18944458 |
| 149 | regulation of tight junction assembly (GO:2000810) | 2.18787255 |
| 150 | cellular response to nutrient (GO:0031670) | 2.18656976 |
| 151 | activation of JUN kinase activity (GO:0007257) | 2.18393270 |
| 152 | cell volume homeostasis (GO:0006884) | 2.17563879 |
| 153 | tricarboxylic acid cycle (GO:0006099) | 2.17145131 |
| 154 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.17092270 |
| 155 | cell communication by electrical coupling (GO:0010644) | 2.17042394 |
| 156 | glial cell proliferation (GO:0014009) | 2.16952261 |
| 157 | actin-myosin filament sliding (GO:0033275) | 2.16659779 |
| 158 | muscle filament sliding (GO:0030049) | 2.16659779 |
| 159 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.16595833 |
| 160 | protein localization to microtubule (GO:0035372) | 2.16452989 |
| 161 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.16054091 |
| 162 | cardiac muscle contraction (GO:0060048) | 2.15849739 |
| 163 | oxaloacetate metabolic process (GO:0006107) | 2.15347756 |
| 164 | cortical actin cytoskeleton organization (GO:0030866) | 2.14023885 |
| 165 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.13872227 |
| 166 | actomyosin structure organization (GO:0031032) | 2.12491673 |
| 167 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.12309407 |
| 168 | renal absorption (GO:0070293) | 2.11632908 |
| 169 | positive regulation of nuclease activity (GO:0032075) | 2.11598442 |
| 170 | epoxygenase P450 pathway (GO:0019373) | 2.11414093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.27953690 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.09237241 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.03396569 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96589758 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76676575 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.53326086 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45368850 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45292410 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31551270 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.29184795 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28241864 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20573732 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09794930 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04165533 |
| 15 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03520920 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.96078709 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95784985 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94054010 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92699758 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85037315 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.84987720 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.83113174 |
| 23 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74390923 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73142548 |
| 25 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.72853992 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.69326205 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69008368 |
| 28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68974582 |
| 29 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.66152270 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64781042 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59933025 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.57688788 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.57508144 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56992438 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56992438 |
| 36 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56663371 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56045952 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54260711 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48829640 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47733153 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47560935 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47072521 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.46242225 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.43904421 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42307284 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42023456 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40215542 |
| 48 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.39431245 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.38906947 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37575218 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37331537 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37093890 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37030906 |
| 54 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36215176 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35583627 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.35155344 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32197760 |
| 58 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31480709 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30308272 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28421047 |
| 61 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23574141 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23339108 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23214310 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23160845 |
| 65 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22904074 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20585838 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20293103 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19630486 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19513866 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19459408 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19226746 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19122452 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18387520 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17798991 |
| 75 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17086171 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15923457 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15808269 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15291880 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14914335 |
| 80 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14533399 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14465113 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14201771 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13194793 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12818553 |
| 85 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12507538 |
| 86 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10848903 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10436216 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09430000 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09173334 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07534062 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07120143 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07022134 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06511492 |
| 94 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05654665 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05242503 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04188241 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 1.03361965 |
| 98 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02633934 |
| 99 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02623551 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02084599 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01784813 |
| 102 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01584252 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01551154 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01367686 |
| 105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00403794 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99015369 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98760656 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98634360 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98536990 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.98012954 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97808113 |
| 112 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97171631 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97093275 |
| 114 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96766937 |
| 115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96583762 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96420613 |
| 117 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95510353 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95126649 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95095432 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93757705 |
| 121 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93694831 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93518657 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92631457 |
| 124 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.91997178 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91858461 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91849872 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91227477 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91139120 |
| 129 | MAF_26560356_Chip-Seq_TH1_Human | 0.90818315 |
| 130 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90698133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.71364262 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.63924008 |
| 3 | MP0005451_abnormal_body_composition | 2.75792206 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.70369565 |
| 5 | MP0004130_abnormal_muscle_cell | 2.60227103 |
| 6 | MP0000751_myopathy | 2.54464309 |
| 7 | MP0005275_abnormal_skin_tensile | 2.46138793 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.30815541 |
| 9 | MP0005409_darkened_coat_color | 2.23658450 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.18749410 |
| 11 | MP0001958_emphysema | 2.16171181 |
| 12 | MP0005360_urolithiasis | 2.03655341 |
| 13 | MP0005666_abnormal_adipose_tissue | 2.03032582 |
| 14 | MP0003453_abnormal_keratinocyte_physiol | 2.01464600 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 1.99729808 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 1.94457382 |
| 17 | MP0003303_peritoneal_inflammation | 1.93438379 |
| 18 | MP0003566_abnormal_cell_adhesion | 1.92614297 |
| 19 | MP0003279_aneurysm | 1.90631982 |
| 20 | MP0004087_abnormal_muscle_fiber | 1.79387983 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.79361265 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.79077200 |
| 23 | MP0005375_adipose_tissue_phenotype | 1.75221877 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.71412447 |
| 25 | MP0008260_abnormal_autophagy | 1.70382262 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.64899889 |
| 27 | MP0005330_cardiomyopathy | 1.61605860 |
| 28 | MP0004272_abnormal_basement_membrane | 1.60825624 |
| 29 | MP0003329_amyloid_beta_deposits | 1.60495266 |
| 30 | MP0008961_abnormal_basal_metabolism | 1.56879698 |
| 31 | MP0005670_abnormal_white_adipose | 1.53171146 |
| 32 | MP0004043_abnormal_pH_regulation | 1.51764828 |
| 33 | MP0009840_abnormal_foam_cell | 1.50806611 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.49692496 |
| 35 | MP0000750_abnormal_muscle_regeneration | 1.49171971 |
| 36 | MP0004858_abnormal_nervous_system | 1.48992266 |
| 37 | MP0002089_abnormal_postnatal_growth/wei | 1.48835996 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.47589462 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.47076691 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.46722912 |
| 41 | MP0005501_abnormal_skin_physiology | 1.45196764 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.44716255 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.44704038 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.42068699 |
| 45 | MP0000749_muscle_degeneration | 1.41373388 |
| 46 | MP0002249_abnormal_larynx_morphology | 1.41311600 |
| 47 | MP0000733_abnormal_muscle_development | 1.40598982 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.36369471 |
| 49 | MP0003252_abnormal_bile_duct | 1.34788236 |
| 50 | MP0003283_abnormal_digestive_organ | 1.33568452 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.32905698 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.32676956 |
| 53 | MP0005083_abnormal_biliary_tract | 1.32431384 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.31968952 |
| 55 | MP0004036_abnormal_muscle_relaxation | 1.30752604 |
| 56 | MP0010630_abnormal_cardiac_muscle | 1.28641045 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.27516035 |
| 58 | MP0000858_altered_metastatic_potential | 1.26954804 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.25611375 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.25031657 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.22219211 |
| 62 | MP0000747_muscle_weakness | 1.21620756 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.20670105 |
| 64 | MP0001849_ear_inflammation | 1.19515710 |
| 65 | MP0003646_muscle_fatigue | 1.18796355 |
| 66 | MP0003045_fibrosis | 1.18630323 |
| 67 | MP0002896_abnormal_bone_mineralization | 1.16204543 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.14614276 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.12192813 |
| 70 | MP0004947_skin_inflammation | 1.10983148 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.09095607 |
| 72 | MP0001544_abnormal_cardiovascular_syste | 1.08890793 |
| 73 | MP0005385_cardiovascular_system_phenoty | 1.08890793 |
| 74 | MP0002971_abnormal_brown_adipose | 1.08718371 |
| 75 | MP0005620_abnormal_muscle_contractility | 1.08222953 |
| 76 | MP0002269_muscular_atrophy | 1.07276269 |
| 77 | MP0005365_abnormal_bile_salt | 1.07226281 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 1.07062617 |
| 79 | MP0000516_abnormal_urinary_system | 1.07062617 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.05892389 |
| 81 | MP0000467_abnormal_esophagus_morphology | 1.05474728 |
| 82 | MP0002060_abnormal_skin_morphology | 1.02950616 |
| 83 | MP0003091_abnormal_cell_migration | 1.02502563 |
| 84 | MP0009643_abnormal_urine_homeostasis | 1.01555035 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.01506889 |
| 86 | MP0004381_abnormal_hair_follicle | 1.00975982 |
| 87 | MP0000579_abnormal_nail_morphology | 1.00663090 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.00106121 |
| 89 | MP0000462_abnormal_digestive_system | 0.99228777 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.98747078 |
| 91 | MP0004233_abnormal_muscle_weight | 0.98665520 |
| 92 | MP0009053_abnormal_anal_canal | 0.97916449 |
| 93 | MP0000537_abnormal_urethra_morphology | 0.97448371 |
| 94 | MP0001756_abnormal_urination | 0.97154382 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.96613706 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.96066319 |
| 97 | MP0002796_impaired_skin_barrier | 0.95817059 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.95590716 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.95177308 |
| 100 | MP0003634_abnormal_glial_cell | 0.94908642 |
| 101 | MP0006138_congestive_heart_failure | 0.94343414 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.94206530 |
| 103 | MP0003828_pulmonary_edema | 0.93077850 |
| 104 | MP0005332_abnormal_amino_acid | 0.92720932 |
| 105 | MP0003123_paternal_imprinting | 0.92580033 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.92417279 |
| 107 | MP0000762_abnormal_tongue_morphology | 0.91827320 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.90311732 |
| 109 | MP0004510_myositis | 0.89505558 |
| 110 | MP0009278_abnormal_bone_marrow | 0.89245122 |
| 111 | MP0003075_altered_response_to | 0.88442964 |
| 112 | MP0000609_abnormal_liver_physiology | 0.88250020 |
| 113 | MP0005023_abnormal_wound_healing | 0.87848348 |
| 114 | MP0002098_abnormal_vibrissa_morphology | 0.87069562 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.86833415 |
| 116 | MP0001243_abnormal_dermal_layer | 0.86787345 |
| 117 | MP0000604_amyloidosis | 0.85958145 |
| 118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85769989 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.85340866 |
| 120 | MP0009115_abnormal_fat_cell | 0.83941794 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.81616548 |
| 122 | MP0005621_abnormal_cell_physiology | 0.81554064 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.81176981 |
| 124 | MP0009931_abnormal_skin_appearance | 0.80719030 |
| 125 | MP0006054_spinal_hemorrhage | 0.80514246 |
| 126 | MP0002970_abnormal_white_adipose | 0.79673307 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.77779049 |
| 128 | MP0005369_muscle_phenotype | 0.77258955 |
| 129 | MP0001915_intracranial_hemorrhage | 0.76388956 |
| 130 | MP0002168_other_aberrant_phenotype | 0.75775719 |
| 131 | MP0003436_decreased_susceptibility_to | 0.75730361 |
| 132 | MP0005334_abnormal_fat_pad | 0.74904570 |
| 133 | MP0009672_abnormal_birth_weight | 0.74012636 |
| 134 | MP0010771_integument_phenotype | 0.73923112 |
| 135 | MP0001542_abnormal_bone_strength | 0.73264626 |
| 136 | MP0001666_abnormal_nutrient_absorption | 0.72839291 |
| 137 | MP0002128_abnormal_blood_circulation | 0.71833066 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.70533403 |
| 139 | MP0005390_skeleton_phenotype | 0.69408904 |
| 140 | MP0003448_altered_tumor_morphology | 0.69325890 |
| 141 | MP0000377_abnormal_hair_follicle | 0.67625828 |
| 142 | MP0002108_abnormal_muscle_morphology | 0.67545060 |
| 143 | MP0003942_abnormal_urinary_system | 0.67283447 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.65331337 |
| 145 | MP0005165_increased_susceptibility_to | 0.65216550 |
| 146 | MP0003115_abnormal_respiratory_system | 0.65012344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased connective tissue (HP:0009025) | 3.59353560 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.53613801 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.43761405 |
| 4 | Premature rupture of membranes (HP:0001788) | 3.39172807 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 3.28215386 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.24311085 |
| 7 | Shallow orbits (HP:0000586) | 3.11140452 |
| 8 | Hyperacusis (HP:0010780) | 3.04037016 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 3.03656276 |
| 10 | Sudden death (HP:0001699) | 3.01064207 |
| 11 | Broad metatarsal (HP:0001783) | 2.98368511 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 2.94346715 |
| 13 | Lymphangioma (HP:0100764) | 2.80353950 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 2.78264063 |
| 15 | Difficulty running (HP:0009046) | 2.77954569 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 2.74726504 |
| 17 | Broad face (HP:0000283) | 2.73923024 |
| 18 | Achilles tendon contracture (HP:0001771) | 2.66297883 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 2.66191859 |
| 20 | Abnormality of the Achilles tendon (HP:0005109) | 2.64539056 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 2.64289846 |
| 22 | Myoglobinuria (HP:0002913) | 2.60765444 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.58803146 |
| 24 | Exercise-induced myalgia (HP:0003738) | 2.58718401 |
| 25 | Ventricular tachycardia (HP:0004756) | 2.53938748 |
| 26 | Mitral valve prolapse (HP:0001634) | 2.50703976 |
| 27 | Mitral regurgitation (HP:0001653) | 2.48310433 |
| 28 | Ankle contracture (HP:0006466) | 2.46951441 |
| 29 | Insomnia (HP:0100785) | 2.46649301 |
| 30 | Difficulty climbing stairs (HP:0003551) | 2.46486065 |
| 31 | Muscle fiber splitting (HP:0003555) | 2.45791981 |
| 32 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45425160 |
| 33 | Asymmetry of the thorax (HP:0001555) | 2.42589175 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39977100 |
| 35 | Aneurysm (HP:0002617) | 2.39062369 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33356161 |
| 37 | Aortic dissection (HP:0002647) | 2.33035576 |
| 38 | Distal upper limb amyotrophy (HP:0007149) | 2.30502117 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.30502117 |
| 40 | Deep venous thrombosis (HP:0002625) | 2.27984347 |
| 41 | Bladder diverticulum (HP:0000015) | 2.24091748 |
| 42 | Short nail (HP:0001799) | 2.23935501 |
| 43 | Atrophic scars (HP:0001075) | 2.22752067 |
| 44 | Aortic aneurysm (HP:0004942) | 2.22119528 |
| 45 | Hyperparathyroidism (HP:0000843) | 2.20656259 |
| 46 | Thin bony cortex (HP:0002753) | 2.20549592 |
| 47 | Turricephaly (HP:0000262) | 2.18997600 |
| 48 | Generalized amyotrophy (HP:0003700) | 2.18788173 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.18620585 |
| 50 | Ketoacidosis (HP:0001993) | 2.18608844 |
| 51 | Bundle branch block (HP:0011710) | 2.17776030 |
| 52 | Wormian bones (HP:0002645) | 2.15032298 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13740198 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.13740198 |
| 55 | Stridor (HP:0010307) | 2.12780773 |
| 56 | Disproportionate tall stature (HP:0001519) | 2.12779655 |
| 57 | Dilatation of the ascending aorta (HP:0005111) | 2.12237531 |
| 58 | Fragile skin (HP:0001030) | 2.11109271 |
| 59 | Scapular winging (HP:0003691) | 2.10437919 |
| 60 | Long toe (HP:0010511) | 2.10380173 |
| 61 | Conjunctival hamartoma (HP:0100780) | 2.08232497 |
| 62 | Elbow flexion contracture (HP:0002987) | 2.08018097 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.07318789 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.06761720 |
| 65 | Vascular tortuosity (HP:0004948) | 2.06267130 |
| 66 | Peritonitis (HP:0002586) | 2.05481683 |
| 67 | Flat acetabular roof (HP:0003180) | 2.03114448 |
| 68 | Limb-girdle muscle atrophy (HP:0003797) | 2.01905228 |
| 69 | Arterial tortuosity (HP:0005116) | 2.01756282 |
| 70 | Hamartoma of the eye (HP:0010568) | 2.01752756 |
| 71 | Rectal prolapse (HP:0002035) | 1.98201262 |
| 72 | Spinal rigidity (HP:0003306) | 1.98127190 |
| 73 | Gout (HP:0001997) | 1.96256629 |
| 74 | Spinal cord compression (HP:0002176) | 1.95783526 |
| 75 | Hand muscle atrophy (HP:0009130) | 1.94366766 |
| 76 | Xanthomatosis (HP:0000991) | 1.94358911 |
| 77 | Polycythemia (HP:0001901) | 1.94053236 |
| 78 | Frequent falls (HP:0002359) | 1.93361674 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92916543 |
| 80 | Biconcave vertebral bodies (HP:0004586) | 1.92911710 |
| 81 | Abnormality of the calf musculature (HP:0001430) | 1.91472621 |
| 82 | Enlarged penis (HP:0000040) | 1.91058964 |
| 83 | Genu recurvatum (HP:0002816) | 1.90571805 |
| 84 | EMG: myopathic abnormalities (HP:0003458) | 1.89531822 |
| 85 | Neurofibrillary tangles (HP:0002185) | 1.87481957 |
| 86 | Myopathic facies (HP:0002058) | 1.86326067 |
| 87 | Lower limb amyotrophy (HP:0007210) | 1.85828234 |
| 88 | Ketosis (HP:0001946) | 1.85518984 |
| 89 | Visceral angiomatosis (HP:0100761) | 1.84720031 |
| 90 | Myocardial infarction (HP:0001658) | 1.83344244 |
| 91 | Atrioventricular block (HP:0001678) | 1.82045147 |
| 92 | Ulnar bowing (HP:0003031) | 1.81602769 |
| 93 | Dysostosis multiplex (HP:0000943) | 1.81537832 |
| 94 | Subaortic stenosis (HP:0001682) | 1.81178792 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81178792 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 1.81071208 |
| 97 | Bronchomalacia (HP:0002780) | 1.80313728 |
| 98 | Back pain (HP:0003418) | 1.80051374 |
| 99 | Trismus (HP:0000211) | 1.79026404 |
| 100 | Cervical subluxation (HP:0003308) | 1.78639161 |
| 101 | Lipoatrophy (HP:0100578) | 1.78386471 |
| 102 | Long palpebral fissure (HP:0000637) | 1.77605474 |
| 103 | Advanced eruption of teeth (HP:0006288) | 1.77578761 |
| 104 | Renal duplication (HP:0000075) | 1.76445436 |
| 105 | Subacute progressive viral hepatitis (HP:0006572) | 1.76039789 |
| 106 | Bulbar palsy (HP:0001283) | 1.76012038 |
| 107 | Slender build (HP:0001533) | 1.74572122 |
| 108 | Nuclear cataract (HP:0100018) | 1.72985467 |
| 109 | Overriding aorta (HP:0002623) | 1.72703589 |
| 110 | Patellar dislocation (HP:0002999) | 1.72170821 |
| 111 | Round ear (HP:0100830) | 1.71841478 |
| 112 | Deviation of the hallux (HP:0010051) | 1.71241684 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.71053127 |
| 114 | Striae distensae (HP:0001065) | 1.71005456 |
| 115 | Mesangial abnormality (HP:0001966) | 1.70505938 |
| 116 | Congenital glaucoma (HP:0001087) | 1.70189920 |
| 117 | Hypercortisolism (HP:0001578) | 1.70077766 |
| 118 | Bowed forearm bones (HP:0003956) | 1.69730300 |
| 119 | Bowing of the arm (HP:0006488) | 1.69730300 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69038066 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.69038066 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 1.68425133 |
| 123 | Abnormality of the thoracic spine (HP:0100711) | 1.68357091 |
| 124 | Natal tooth (HP:0000695) | 1.68166127 |
| 125 | Hyperextensible skin (HP:0000974) | 1.67516088 |
| 126 | Hemangiomatosis (HP:0007461) | 1.67436546 |
| 127 | Hallux valgus (HP:0001822) | 1.67373832 |
| 128 | Calf muscle hypertrophy (HP:0008981) | 1.66576486 |
| 129 | Elfin facies (HP:0004428) | 1.65785364 |
| 130 | Abnormal ossification of hand bones (HP:0005921) | 1.64804752 |
| 131 | Syringomyelia (HP:0003396) | 1.64480311 |
| 132 | Spinal cord lesions (HP:0100561) | 1.64480311 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.63726908 |
| 134 | Foot dorsiflexor weakness (HP:0009027) | 1.63515799 |
| 135 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.62845629 |
| 136 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.62845629 |
| 137 | Abnormality of glycolipid metabolism (HP:0010969) | 1.62845629 |
| 138 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.62781179 |
| 139 | Hypercalcemia (HP:0003072) | 1.62747105 |
| 140 | Heart block (HP:0012722) | 1.62638050 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.62599315 |
| 142 | Blue sclerae (HP:0000592) | 1.62568660 |
| 143 | Acanthosis nigricans (HP:0000956) | 1.61929321 |
| 144 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.61900870 |
| 145 | Atrial fibrillation (HP:0005110) | 1.61476192 |
| 146 | Axonal loss (HP:0003447) | 1.60637402 |
| 147 | Ventricular arrhythmia (HP:0004308) | 1.60381948 |
| 148 | Hematochezia (HP:0002573) | 1.60342111 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.60235054 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.60235054 |
| 151 | Arnold-Chiari malformation (HP:0002308) | 1.59652192 |
| 152 | Complement deficiency (HP:0004431) | 1.59647824 |
| 153 | Late onset (HP:0003584) | 1.58498398 |
| 154 | Wide anterior fontanel (HP:0000260) | 1.57430802 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.57104574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 6.43391147 |
| 2 | PKN2 | 4.34810069 |
| 3 | TTN | 3.50457045 |
| 4 | IRAK3 | 3.17823868 |
| 5 | PRPF4B | 3.00570242 |
| 6 | SMG1 | 2.96894107 |
| 7 | RIPK1 | 2.77464641 |
| 8 | EPHA2 | 2.66248632 |
| 9 | ERN1 | 2.48866163 |
| 10 | NME2 | 2.25387071 |
| 11 | PDGFRA | 2.13705248 |
| 12 | PTK6 | 2.13382148 |
| 13 | LMTK2 | 1.90305081 |
| 14 | EEF2K | 1.90220152 |
| 15 | SIK1 | 1.87061101 |
| 16 | MAP3K10 | 1.85994697 |
| 17 | DDR2 | 1.79644411 |
| 18 | BMX | 1.62301671 |
| 19 | EPHB2 | 1.53306333 |
| 20 | ICK | 1.49947007 |
| 21 | LRRK2 | 1.48196250 |
| 22 | DMPK | 1.47602552 |
| 23 | BCKDK | 1.36942847 |
| 24 | TAOK2 | 1.34679303 |
| 25 | PRKD3 | 1.32997814 |
| 26 | PHKG2 | 1.31156520 |
| 27 | PHKG1 | 1.31156520 |
| 28 | CDK12 | 1.27596864 |
| 29 | TGFBR2 | 1.24109310 |
| 30 | EPHB1 | 1.22586321 |
| 31 | CAMK1D | 1.20287482 |
| 32 | ARAF | 1.19224392 |
| 33 | CAMKK1 | 1.15957382 |
| 34 | TAOK1 | 1.14917168 |
| 35 | ILK | 1.11460724 |
| 36 | LATS1 | 1.09947182 |
| 37 | MST1R | 1.09554571 |
| 38 | FER | 1.09127662 |
| 39 | PAK4 | 1.09028895 |
| 40 | LATS2 | 1.07793383 |
| 41 | RPS6KB2 | 1.04032689 |
| 42 | CAMK1G | 0.99575499 |
| 43 | KSR2 | 0.98545490 |
| 44 | RET | 0.97886558 |
| 45 | DAPK2 | 0.97806968 |
| 46 | MAP3K7 | 0.94721126 |
| 47 | IRAK2 | 0.94460391 |
| 48 | FGFR4 | 0.94436499 |
| 49 | PTK2 | 0.94188933 |
| 50 | NEK1 | 0.89615008 |
| 51 | MAP3K13 | 0.89525553 |
| 52 | PRKCH | 0.88335917 |
| 53 | MARK2 | 0.85043178 |
| 54 | PAK6 | 0.83617328 |
| 55 | PRKD1 | 0.83295737 |
| 56 | ALK | 0.83143830 |
| 57 | MAP3K2 | 0.82048673 |
| 58 | DAPK3 | 0.81738598 |
| 59 | MAP2K3 | 0.78850742 |
| 60 | PDGFRB | 0.78077219 |
| 61 | PAK2 | 0.77958618 |
| 62 | MAP3K9 | 0.75602377 |
| 63 | MTOR | 0.75432998 |
| 64 | DYRK1B | 0.75412962 |
| 65 | STK38 | 0.75226188 |
| 66 | TYRO3 | 0.73807532 |
| 67 | TESK2 | 0.73495418 |
| 68 | LIMK1 | 0.73041535 |
| 69 | CDK6 | 0.72947891 |
| 70 | PDPK1 | 0.71441786 |
| 71 | WNK4 | 0.71217732 |
| 72 | RPS6KL1 | 0.70971379 |
| 73 | RPS6KC1 | 0.70971379 |
| 74 | MOS | 0.69900790 |
| 75 | NTRK1 | 0.69796444 |
| 76 | BRAF | 0.68277091 |
| 77 | SCYL2 | 0.67591703 |
| 78 | NEK9 | 0.66658366 |
| 79 | PDK3 | 0.65412280 |
| 80 | PDK4 | 0.65412280 |
| 81 | TIE1 | 0.63111844 |
| 82 | MAP3K6 | 0.63041257 |
| 83 | MAP3K3 | 0.62862608 |
| 84 | MAP2K1 | 0.62781529 |
| 85 | PRKD2 | 0.62523741 |
| 86 | MAP3K8 | 0.61991840 |
| 87 | MAP3K11 | 0.61963225 |
| 88 | PTK2B | 0.61678290 |
| 89 | MAP2K2 | 0.60939221 |
| 90 | PIM2 | 0.59213307 |
| 91 | ROCK1 | 0.57971912 |
| 92 | MYLK | 0.57330589 |
| 93 | PAK3 | 0.57315113 |
| 94 | IRAK4 | 0.56899051 |
| 95 | JAK2 | 0.54847093 |
| 96 | MAP3K1 | 0.54446762 |
| 97 | CAMK2G | 0.52857267 |
| 98 | JAK1 | 0.52385716 |
| 99 | TBK1 | 0.51056260 |
| 100 | FGFR3 | 0.50777294 |
| 101 | MAPK11 | 0.50659563 |
| 102 | RPS6KA2 | 0.49803765 |
| 103 | OBSCN | 0.49597687 |
| 104 | MET | 0.48584803 |
| 105 | ABL2 | 0.47417843 |
| 106 | CDC42BPA | 0.46761405 |
| 107 | RPS6KA6 | 0.46702880 |
| 108 | SIK2 | 0.46616658 |
| 109 | PRKG2 | 0.46278365 |
| 110 | ROCK2 | 0.45007357 |
| 111 | CDK7 | 0.44811507 |
| 112 | CSK | 0.44432705 |
| 113 | PDK1 | 0.44008747 |
| 114 | MUSK | 0.42755265 |
| 115 | PRKAA1 | 0.42195437 |
| 116 | FGFR1 | 0.41159664 |
| 117 | MAPKAPK2 | 0.41107573 |
| 118 | AKT2 | 0.40553820 |
| 119 | ERBB2 | 0.40245089 |
| 120 | GSK3A | 0.40192230 |
| 121 | CAMK2B | 0.40081597 |
| 122 | CDK4 | 0.39823326 |
| 123 | SGK3 | 0.38646763 |
| 124 | FLT3 | 0.37835894 |
| 125 | WNK1 | 0.37831073 |
| 126 | HIPK2 | 0.37608808 |
| 127 | PRKAA2 | 0.37523791 |
| 128 | ZAP70 | 0.37110274 |
| 129 | TESK1 | 0.36471357 |
| 130 | RPS6KA1 | 0.36423351 |
| 131 | MAPK4 | 0.35992041 |
| 132 | MAPKAPK3 | 0.35477869 |
| 133 | MAPK12 | 0.35274622 |
| 134 | AURKA | 0.31768525 |
| 135 | CDK8 | 0.30874209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49731523 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.46705917 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33297966 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.30213990 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.19683671 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08320483 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06158462 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93640784 |
| 9 | Prion diseases_Homo sapiens_hsa05020 | 1.75714921 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68473615 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68424676 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62332058 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.60060836 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59272111 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56826207 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50682872 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48393077 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47138145 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.39455615 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.34042716 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.31748884 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.31233326 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31227915 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28063509 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27535408 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.26355362 |
| 27 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.24861052 |
| 28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.22180825 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20395896 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19422922 |
| 31 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16700903 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15750588 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14765082 |
| 34 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.13250423 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11241372 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09948516 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.08455528 |
| 38 | Bladder cancer_Homo sapiens_hsa05219 | 1.08320466 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07714697 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06396989 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05549678 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03548439 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.03458268 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.02650033 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.02462073 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.02460656 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.01803316 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00050812 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97917445 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97153198 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95815712 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94870247 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92667815 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92325931 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.91607899 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90391809 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90339982 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89881245 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.89732280 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89652761 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89414287 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89157361 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89028311 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86998166 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86923502 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86092382 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84364672 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83865032 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83705749 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83650668 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83537510 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83283614 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83068012 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.82841011 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.82209231 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82169568 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81752888 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81082626 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80934614 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80155793 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79270563 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79136845 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79119295 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.78586138 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78317565 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78056253 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.77415824 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.77156405 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77080304 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76624841 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76472828 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75820460 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74157378 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73786392 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.73493008 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73037372 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71951169 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.71736356 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71598189 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71351794 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.69485012 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.69036938 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68805885 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68520434 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.68062532 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66209482 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66181712 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63834525 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62212335 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62204350 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61881169 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61195294 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.60763036 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60525979 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60471970 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60246585 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57952240 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56531609 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56360200 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55886665 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55369675 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54957960 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54726167 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54412168 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53525244 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.52175005 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.52154290 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51764038 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51637391 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.51399342 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51325032 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50182546 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49617752 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49285427 |
| 135 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48831162 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48770965 |
| 137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48739677 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48623092 |
| 139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48115824 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47707553 |
| 141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47130968 |
| 142 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46709495 |
| 143 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45966468 |
| 144 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44072595 |
| 145 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43393368 |

